Related references
Note: Only part of the references are listed.Interaction of cannabidiol with other antiseizure medications: A narrative review
Christopher G. S. Gilmartin et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2021)
Cannabidiol as a treatment for craving and relapse in individuals with cocaine use disorder: a randomized placebo-controlled trial
Violaine Mongeau-Perusse et al.
ADDICTION (2021)
Cannabidiol attenuated the maintenance and reinstatement of extinguished methylphenidate-induced conditioned place preference in rats
Adel Kashefi et al.
BRAIN RESEARCH BULLETIN (2021)
Cannabidiol prevents priming- and stress-induced reinstatement of the conditioned place preference induced by cocaine in mice
Claudia Calpe-Lopez et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2021)
Developmental cannabidiol exposure increases anxiety and modifies genome-wide brain DNA methylation in adult female mice
Nicole M. Wanner et al.
CLINICAL EPIGENETICS (2021)
A survey of cannabinoids and toxic elements in hemp-derived products from the United States marketplace
Geoffrey A. Dubrow et al.
JOURNAL OF FOOD COMPOSITION AND ANALYSIS (2021)
The emerging role of cannabidiol (CBD) products; a survey exploring the public's use and perceptions of CBD
Sukvinder Kaur Bhamra et al.
PHYTOTHERAPY RESEARCH (2021)
Cannabidiol treatment in an adolescent with multiple substance abuse, social anxiety and depression
Clarissa Laczkovics et al.
NEUROPSYCHIATRIE (2021)
Gender differences in the effects of cannabidiol on ethanol binge drinking in mice
Adrian Viudez-Martinez et al.
ADDICTION BIOLOGY (2020)
The pharmacological reduction of hippocampal neurogenesis attenuates the protective effects of cannabidiol on cocaine voluntary intake
Miguel Angel Lujan et al.
ADDICTION BIOLOGY (2020)
Cannabidiol attenuates the rewarding effects of cocaine in rats by CB2, 5-HT1A and TRPV1 receptor mechanisms
Ewa Galaj et al.
NEUROPHARMACOLOGY (2020)
Neuroprotective effect of chronic administration of cannabidiol during the abstinence period on methamphetamine-induced impairment of recognition memory in the rats
Yasaman Razavi et al.
BEHAVIOURAL PHARMACOLOGY (2020)
Cannabidiol modulates the expression of neuroinflammatory factors in stress- and drug-induced reinstatement of methamphetamine in extinguished rats
Saeideh Karimi-Haghighi et al.
ADDICTION BIOLOGY (2020)
Adverse effects of cannabidiol: a systematic review and meta-analysis of randomized clinical trials
Edward Chesney et al.
NEUROPSYCHOPHARMACOLOGY (2020)
Cannabidiol (CBD) reduces cocaine-environment memory in mice
Rose Chesworth et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2020)
Cannabinoids and the endocannabinoid system in reward processing and addiction: from mechanisms to interventions
Rainer Spanagel
DIALOGUES IN CLINICAL NEUROSCIENCE (2020)
Use of Cannabidiol for the Treatment of Anxiety: A Short Synthesis of Pre-Clinical and Clinical Evidence
Madison Wright et al.
CANNABIS AND CANNABINOID RESEARCH (2020)
Cannabidiol attenuates methamphetamine-induced conditioned place preference via the Sigma1R/AKT/GSK-3β/CREB signaling pathway in rats
Genmeng Yang et al.
TOXICOLOGY RESEARCH (2020)
Cannabidiol for the treatment of cannabis use disorder: a phase 2a, double-blind, placebo-controlled, randomised, adaptive Bayesian trial
Tom P. Freeman et al.
LANCET PSYCHIATRY (2020)
Lack of evidence for the effectiveness or safety of over-the-counter cannabidiol products
Edward Chesney et al.
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY (2020)
Is there a role for cannabidiol in psychiatry?
Julia Machado Khoury et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2019)
Cannabinoid CB1 receptor neutral antagonist AM4113 inhibits heroin self-administration without depressive side effects in rats
Xiang-hu He et al.
ACTA PHARMACOLOGICA SINICA (2019)
Cannabidiol for the Reduction of Cue-Induced Craving and Anxiety in Drug-Abstinent Individuals With Heroin Use Disorder: A Double-Blind Randomized Placebo-Controlled Trial
Yasmin L. Hurd et al.
AMERICAN JOURNAL OF PSYCHIATRY (2019)
Pharmacotherapy for Cocaine Use Disorder-a Systematic Review and Meta-analysis
Brian Chan et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2019)
Cannabidiol presents an inverted U-shaped dose-response curve in a simulated public speaking test
Ila M. Linares et al.
BRAZILIAN JOURNAL OF PSYCHIATRY (2019)
Effects of Cannabidiol on Morphine Conditioned Place Preference in Mice
James Roland Markos et al.
PLANTA MEDICA (2018)
Cannabidiol reverses attentional bias to cigarette cues in a human experimental model of tobacco withdrawal
Chandni Hindocha et al.
ADDICTION (2018)
Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial
Philip McGuire et al.
AMERICAN JOURNAL OF PSYCHIATRY (2018)
Trends in US Drug Overdose Deaths in Non-Hispanic Black, Hispanic, and Non-Hispanic White Persons, 2000-2015
Meredith S. Shiels et al.
ANNALS OF INTERNAL MEDICINE (2018)
Effects of cannabidiol plus naltrexone on motivation and ethanol consumption
Adrian Viudez-Martinez et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
Cannabis Addiction and the Brain: a Review
Amna Zehra et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2018)
Cannabinoid-1 receptor neutral antagonist reduces binge-like alcohol consumption and alcohol-induced accumbal dopaminergic signaling
Andrea Balla et al.
NEUROPHARMACOLOGY (2018)
Unique treatment potential of cannabidiol for the prevention of relapse to drug use: preclinical proof of principle
Gustavo Gonzalez-Cuevas et al.
NEUROPSYCHOPHARMACOLOGY (2018)
Cannabidiol inhibits priming-induced reinstatement of methamphetamine in REM sleep deprived rats
Saeideh Karimi-Haghighi et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2018)
The effects of cannabidiol on impulsivity and memory during abstinence in cigarette dependent smokers
C. Hindocha et al.
SCIENTIFIC REPORTS (2018)
Cannabidiol treatment reduces the motivation to self-administer methamphetamine and methamphetamine-primed relapse in rats
Gracie L. Hay et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2018)
Repeated Cannabidiol treatment reduces cocaine intake and modulates neural proliferation and CB1R expression in the mouse hippocampus
Miguel Angel Lujan et al.
NEUROPHARMACOLOGY (2018)
A Systematic Review on the Pharmacokinetics of Cannabidiol in Humans
Sophie A. Millar et al.
FRONTIERS IN PHARMACOLOGY (2018)
Cannabidiol reduces ethanol consumption, motivation and relapse in mice
Adrian Viudez-Martinez et al.
ADDICTION BIOLOGY (2018)
Cannabidiol disrupts the reconsolidation of contextual drug-associated memories in Wistar rats
Cristiane Ribeiro de Carvalho et al.
ADDICTION BIOLOGY (2017)
Effects of an acute cannabidiol treatment on cocaine self-administration and cue-induced cocaine seeking in male rats
Ashraf Mahmud et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2017)
The CB1 Neutral Antagonist AM4113 Retains the Therapeutic Efficacy of the Inverse Agonist Rimonabant for Nicotine Dependence and Weight Loss with Better Psychiatric Tolerability
Aliou B. Gueye et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2016)
Cannabidiol Counteracts Amphetamine-Induced Neuronal and Behavioral Sensitization of the Mesolimbic Dopamine Pathway through a NovelmTOR/p70S6Kinase Signaling Pathway
Justine Renard et al.
JOURNAL OF NEUROSCIENCE (2016)
Liking, Wanting, and the Incentive-Sensitization Theory of Addiction
Kent C. Berridge et al.
AMERICAN PSYCHOLOGIST (2016)
Safety and Pharmacokinetics of Oral Cannabidiol When Administered Concomitantly With Intravenous Fentanyl in Humans
Alex F. Manini et al.
JOURNAL OF ADDICTION MEDICINE (2015)
Early Phase in the Development of Cannabidiol as a Treatment for Addiction: Opioid Relapse Takes Initial Center Stage
Yasmin L. Hurd et al.
NEUROTHERAPEUTICS (2015)
The Endocannabinoid System and its Modulation by Phytocannabinoids
Vincenzo Di Marzo et al.
NEUROTHERAPEUTICS (2015)
Cannabinoid Modulation of Functional Connectivity within Regions Processing Attentional Salience
Sagnik Bhattacharyya et al.
NEUROPSYCHOPHARMACOLOGY (2015)
Nabiximols as an Agonist Replacement Therapy During Cannabis Withdrawal A Randomized Clinical Trial
David J. Allsop et al.
JAMA PSYCHIATRY (2014)
Cannabidiol inhibits the reward-facilitating effect of morphine: involvement of 5-HT1A receptors in the dorsal raphe nucleus
Vicky Katsidoni et al.
ADDICTION BIOLOGY (2013)
Cannabidiol reduces cigarette consumption in tobacco smokers: Preliminary findings
Celia J. A. Morgan et al.
ADDICTIVE BEHAVIORS (2013)
Cannabidiol for the treatment of cannabis withdrawal syndrome: a case report
J. A. S. Crippa et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2013)
Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment
Amir Englund et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2013)
Extent of illicit drug use and dependence, and their contribution to the global burden of disease
Louisa Degenhardt et al.
LANCET (2012)
Subjective and Physiological Effects After Controlled Sativex and Oral THC Administration
E. L. Karschner et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
Potent inhibition of human cytochrome P450 3A isoforms by cannabidiol: Role of phenolic hydroxyl groups in the resorcinol moiety
Satoshi Yamaori et al.
LIFE SCIENCES (2011)
Cannabidiol potentiates Δ9-tetrahydrocannabinol (THC) behavioural effects and alters THC pharmacokinetics during acute and chronic treatment in adolescent rats
Charlotte Klein et al.
PSYCHOPHARMACOLOGY (2011)
Antidepressant-like effects of cannabidiol in mice: possible involvement of 5-HT1A receptors
T. V. Zanelati et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Impact of cannabidiol on the acute and psychotomimetic effects of smoked cannabis: naturalistic study
Celia J. A. Morgan et al.
BRITISH JOURNAL OF PSYCHIATRY (2010)
Cannabidiol Attenuates the Appetitive Effects of Δ9-Tetrahydrocannabinol in Humans Smoking Their Chosen Cannabis
Celia J. A. Morgan et al.
NEUROPSYCHOPHARMACOLOGY (2010)
Cannabidiol, a Nonpsychotropic Component of Cannabis, Inhibits Cue-Induced Heroin Seeking and Normalizes Discrete Mesolimbic Neuronal Disturbances
Yanhua Ren et al.
JOURNAL OF NEUROSCIENCE (2009)
Poor response inhibition: At the nexus between substance abuse and attention deficit/hyperactivity disorder
Stephanie M. Groman et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2009)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
PLOS MEDICINE (2009)
Cannabidiol potentiates pharmacological effects of Δ9-tetrahydrocannabinol via CB1 receptor-dependent mechanism
Kazuhide Hayakawa et al.
BRAIN RESEARCH (2008)
The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Delta(9)-tetrahydrocannabinol, cannabidiol and Delta(9)-tetrahydrocannabivarin
R. G. Pertwee
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Divergent effects of cannabidiol on the discriminative stimulus and place conditioning effects of Δ9-tetrahydrocannabinol
Robert E. Vann et al.
DRUG AND ALCOHOL DEPENDENCE (2008)
Enhancement of endocannabinoid neurotransmission through CB1 cannabinoid receptors counteracts the reinforcing and psychostimulant effects of cocaine
Styliani Vlachou et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2008)
Meta-analysis of Go/No-go tasks, demonstrating that fMRI activation associated with response inhibition is task-dependent
Daniel J. Simmonds et al.
NEUROPSYCHOLOGIA (2008)
Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro
A. Thomas et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Understanding the health impact of alcohol dependence
Thomas Cargiulo
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2007)
Randomized, double-blind, placebo-controlled study about the effects of cannabidiol (CBD) on the pharmacokinetics of Δ9-tetrahydrocannabinol (THC) after oral application of THC verses standardized cannabis extract
T Nadulski et al.
THERAPEUTIC DRUG MONITORING (2005)
Agonistic properties of cannabidiol at 5-HT1a receptors
EB Russo et al.
NEUROCHEMICAL RESEARCH (2005)
Cannabinoid CB1 receptor antagonists as promising new medications for drug dependence
B Le Foll et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
SR141716, a central cannabinoid (CB1) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats
C Cohen et al.
BEHAVIOURAL PHARMACOLOGY (2002)
Stimulation of voluntary ethanol intake by cannabinoid receptor agonists in ethanol-preferring sP rats
G Colombo et al.
PSYCHOPHARMACOLOGY (2002)
Share Paper
